Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Endocrinol
2015 Jun 01;296:933-42. doi: 10.1210/me.2015-1044.
Show Gene links
Show Anatomy links
Structural insights into thyroid hormone transport mechanisms of the L-type amino acid transporter 2.
Hinz KM
,
Meyer K
,
Kinne A
,
Schülein R
,
Köhrle J
,
Krause G
.
???displayArticle.abstract???
Thyroid hormones (THs) are transported across cell membranes by different transmembrane transporter proteins. In previous studies, we showed marked 3,3'-diiodothyronine (3,3'-T2) but moderate T3 uptake by the L-type amino acid transporter 2 (Lat2). We have now studied the structure-function relationships of this transporter and TH-like molecules. Our Lat2 homology model is based on 2 crystal structures of the homologous 12-transmembrane helix transporters arginine/agmatine antiporter and amino acid/polyamine/organocation transporter. Model-driven mutagenesis of residues lining an extracellular recognition site and a TH-traversing channel identified 9 sensitive residues. Using Xenopus laevis oocytes as expression system, we found that side chain shortening (N51S, N133S, N248S, and Y130A) expanded the channel and increased 3,3'-T2 transport. Side chain enlargements (T140F, Y130R, and I137M) decreased 3,3'-T2 uptake, indicating channel obstructions. The opposite results with mutations maintaining (F242W) or impairing (F242V) uptake suggest that F242 may have a gating function. Competitive inhibition studies of 14 TH-like compounds revealed that recognition by Lat2 requires amino and carboxylic acid groups. The size of the adjacent hydrophobic group is restricted. Bulky substituents in positions 3 and 5 of the tyrosine ring are allowed. The phenolic ring may be enlarged, provided that the whole molecule is flexible enough to fit into the distinctly shaped TH-traversing channel of Lat2. Taken together, the next Lat2 features were identified 1) TH recognition site; 2) TH-traversing channel in the center of Lat2; and 3) switch site that potentially facilitates intracellular substrate release. Together with identified substrate features, these data help to elucidate the molecular mechanisms and role of Lat2 in T2 transport.
Abe,
Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2.
1998, Pubmed
Abe,
Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2.
1998,
Pubmed
Ball,
3,5-Diiodo-L-thyronine (T2) has selective thyromimetic effects in vivo and in vitro.
1997,
Pubmed
Beuming,
A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function.
2006,
Pubmed
Braun,
Histidines in potential substrate recognition sites affect thyroid hormone transport by monocarboxylate transporter 8 (MCT8).
2013,
Pubmed
,
Xenbase
Christensen,
Role of amino acid transport and countertransport in nutrition and metabolism.
1990,
Pubmed
Claxton,
Ion/substrate-dependent conformational dynamics of a bacterial homolog of neurotransmitter:sodium symporters.
2010,
Pubmed
Fang,
Structure of a prokaryotic virtual proton pump at 3.2 A resolution.
2009,
Pubmed
Forrest,
The rocking bundle: a mechanism for ion-coupled solute flux by symmetrical transporters.
2009,
Pubmed
Friesema,
Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation.
,
Pubmed
Friesema,
Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10.
2008,
Pubmed
Friesema,
Thyroid hormone transport by the heterodimeric human system L amino acid transporter.
2001,
Pubmed
,
Xenbase
Friesema,
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter.
2003,
Pubmed
,
Xenbase
Gao,
Mechanism of substrate recognition and transport by an amino acid antiporter.
2010,
Pubmed
Gao,
Structure and mechanism of an amino acid antiporter.
2009,
Pubmed
Gasol,
Membrane topology of system xc- light subunit reveals a re-entrant loop with substrate-restricted accessibility.
2004,
Pubmed
Geier,
Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1.
2013,
Pubmed
Hagenbuch,
The SLCO (former SLC21) superfamily of transporters.
2013,
Pubmed
Huang,
Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli.
2003,
Pubmed
Jansen,
Thyroid hormone transporters in health and disease.
2005,
Pubmed
,
Xenbase
Jonas,
3,5-Diiodo-L-thyronine (3,5-t2) exerts thyromimetic effects on hypothalamus-pituitary-thyroid axis, body composition, and energy metabolism in male diet-induced obese mice.
2015,
Pubmed
Kanai,
Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98).
1998,
Pubmed
,
Xenbase
Khunweeraphong,
Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties.
2012,
Pubmed
Kinne,
Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8.
2010,
Pubmed
Kinne,
Involvement of the L-Type Amino Acid Transporter Lat2 in the Transport of 3,3'-Diiodothyronine across the Plasma Membrane.
2015,
Pubmed
,
Xenbase
Kowalczyk,
Molecular basis of substrate-induced permeation by an amino acid antiporter.
2011,
Pubmed
Lanni,
Specific binding sites for 3,3'-diiodo-L-thyronine (3,3'-T2) in rat liver mitochondria.
1994,
Pubmed
Lehmphul,
Detection of 3,5-diiodothyronine in sera of patients with altered thyroid status using a new monoclonal antibody-based chemiluminescence immunoassay.
2014,
Pubmed
Mendoza,
3,5-T2 is an alternative ligand for the thyroid hormone receptor β1.
2013,
Pubmed
Meury,
Detergent-induced stabilization and improved 3D map of the human heteromeric amino acid transporter 4F2hc-LAT2.
2014,
Pubmed
Mitchell,
Iodothyronine Interactions with the System L1 Amino Acid Exchanger in 3T3-L1 Adipocytes.
2010,
Pubmed
Moreno,
Metabolic effects of thyroid hormone derivatives.
2008,
Pubmed
Morimoto,
Establishment and characterization of mammalian cell lines stably expressing human L-type amino acid transporters.
2008,
Pubmed
,
Xenbase
Müller,
Expression pattern of thyroid hormone transporters in the postnatal mouse brain.
2014,
Pubmed
Nakada,
Unique and selective expression of L-amino acid transporter 1 in human tissue as well as being an aspect of oncofetal protein.
2014,
Pubmed
Navarrete-Ramírez,
3,5-di-iodothyronine stimulates tilapia growth through an alternate isoform of thyroid hormone receptor β1.
2014,
Pubmed
Núñez,
Cerebral cortex hyperthyroidism of newborn mct8-deficient mice transiently suppressed by lat2 inactivation.
2014,
Pubmed
Olivella,
Relation between sequence and structure in membrane proteins.
2013,
Pubmed
Padron,
Administration of 3,5-diiodothyronine (3,5-T2) causes central hypothyroidism and stimulates thyroid-sensitive tissues.
2014,
Pubmed
Pietzner,
Translating pharmacological findings from hypothyroid rodents to euthyroid humans: is there a functional role of endogenous 3,5-T2?
2015,
Pubmed
Pineda,
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
1999,
Pubmed
,
Xenbase
Rao,
Uptake of thyroid hormone by isolated rat liver cells.
1976,
Pubmed
Ritchie,
Thyroid hormone transport by 4F2hc-IU12 heterodimers expressed in Xenopus oocytes.
1999,
Pubmed
,
Xenbase
Ritchie,
Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta.
2001,
Pubmed
Rosell,
Structural bases for the interaction and stabilization of the human amino acid transporter LAT2 with its ancillary protein 4F2hc.
2014,
Pubmed
Rossier,
LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
1999,
Pubmed
,
Xenbase
Schlessinger,
Molecular modeling and ligand docking for solute carrier (SLC) transporters.
2013,
Pubmed
Schlessinger,
SLC classification: an update.
2013,
Pubmed
Shaffer,
Structure and mechanism of a Na+-independent amino acid transporter.
2009,
Pubmed
Shi,
The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site.
2008,
Pubmed
Tohyama,
Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier.
2004,
Pubmed
Trajkovic,
Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8.
2007,
Pubmed
Tsai,
Sided functions of an arginine-agmatine antiporter oriented in liposomes.
2012,
Pubmed
Westholm,
Evidence of evolutionary conservation of function between the thyroxine transporter Oatp1c1 and major facilitator superfamily members.
2010,
Pubmed
Wirth,
Neuronal 3',3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome.
2009,
Pubmed
Wirth,
Transport of thyroid hormone in brain.
2014,
Pubmed
Yamashita,
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters.
2005,
Pubmed
